Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 236 M249 M259 M265 M213 M268 M 1 B Research & development —————— — Operating income 51 M68 M353 M240 M245 M304 M 1.14 B Non-Operating Income, Total 4 M-53 M72 M-69 M-49 M11 M -35 M Interest expense, net of interest capitalized 26 M26 M27 M26 M25 M26 M 104 M Non-Operating Income, excl. Interest Expenses -22 M-79 M45 M-95 M-74 M-15 M -139 M Unusual income/expense —————— — Pretax income 126 M125 M164 M18 M111 M109 M 402 M Equity in earnings —————— — Taxes 36 M35 M9 M4 M31 M26 M 70 M Non-controlling/minority interest 31 M32 M31 M33 M32 M34 M 130 M After tax other income/expense —————— — Net income before discontinued operations 59 M58 M124 M-19 M48 M49 M 202 M Discontinued operations -5 M-7 M-8 M21 M-1 M-2 M 10 M Net income 54 M51 M116 M2 M47 M47 M 212 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 54 M51 M116 M2 M47 M47 M 212 M Basic earnings per share (Basic EPS) 0.130.120.2900.120.12 0.53 Diluted earnings per share (Diluted EPS) 0.130.120.280.010.120.12 0.53 Average basic shares outstanding 418.3 M413.2 M408 M409 M388.1 M381.3 M — Diluted shares outstanding 422.9 M417.5 M413.3 M414 M393.7 M386.3 M — EBITDA 202 M221 M317 M207 M214 M243 M 981 M EBIT 234 M258 M353 M240 M245 M304 M 1.14 B Cost of revenue 1.32 B1.29 B1.32 B1.28 B1.32 B1.33 B 5.25 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) -32 M-37 M-36 M-33 M-31 M-61 M -161 M